Aprea Therapeutics, Inc. (APRE)
0.93
+0.03
(+3.34%)
USD |
NASDAQ |
May 21, 16:00
0.8903
-0.04
(-4.27%)
Pre-Market: 19:59
Aprea Therapeutics EPS Diluted (Quarterly) : -0.2239 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| United Therapeutics Corp. | 5.824 |
| Ernexa Therapeutics, Inc. | -6.952 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Tango Therapeutics, Inc. | -0.317 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.288M |
| Total Expenses (Quarterly) | 3.288M |
| Enterprise Value | -34.22M |
| Earnings Yield | -165.8% |
| Normalized Earnings Yield | -165.82 |